# AQUAPORIN A/S > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/aquaporin). ## Overview AQUAPORIN A/S is a Denmark-based water technology company that develops membrane-based filtration and reuse solutions built around its Aquaporin Inside® technology. Its products and systems are used in applications such as industrial wastewater treatment, food and beverage processing, home water treatment, and specialized space-related use cases, with operations spanning Denmark and several international markets. ## Products & services • Aquaporin Inside® membranes and filtration technology • Industrial wastewater treatment solutions • Water reuse and purification systems • Food and beverage concentration solutions • Residential water filtration products • Technology licensing and partner-enabled solutions - **Membranes and core technology** (35%) — Nature-inspired membrane technology and embedded Aquaporin Inside® solutions used across applications. - **Industrial water treatment** (25%) — Systems for treating and reusing industrial wastewater and process water. - **Food and beverage processing** (15%) — Solutions used to concentrate food and beverage products in processing applications. - **Residential water solutions** (15%) — Home water filtration products for point-of-use drinking water applications. - **Partnerships and licensing** (10%) — Commercial collaborations and technology-enabled deployments with third parties. - Aquaporin Inside® membranes and filtration technology - Industrial wastewater treatment solutions - Water reuse and purification systems - Food and beverage concentration solutions - Residential water filtration products - Technology licensing and partner-enabled solutions ## Customers Aquaporin sells to industrial customers that need water treatment, reuse, and concentration solutions in process environments. It also serves households through residential water filtration products and works with partners and institutions that integrate its membrane technology into specialized systems. Demand is tied to water scarcity, water quality regulation, process efficiency, and the need for lower-impact purification methods. - **Industrial water customers** (primary) — Factories and industrial operators buying wastewater treatment and reuse systems to meet process and compliance needs. - **Food and beverage processors** (secondary) — Producers using membrane technology to concentrate liquids and improve processing efficiency. - **Residential consumers** (secondary) — Households purchasing water filtration products for cleaner drinking water at home. - **Strategic partners** (primary) — OEMs, distributors, and collaborators that incorporate Aquaporin technology into broader solutions. - Industrial users needing wastewater treatment and water reuse - Food and beverage processors requiring concentration solutions - Households buying point-of-use water filtration products - Technology partners integrating membranes into their systems - Specialized customers needing advanced purification capability ## Geography Aquaporin is headquartered in Denmark and operates internationally through sites in Singapore, Turkey, the United States, and China. Its business is therefore exposed to multiple regulatory regimes, supply chains, and local water-treatment markets. This footprint supports global commercialization, while also increasing dependence on cross-border manufacturing, logistics, and partner execution. - **Denmark** — Headquarters and core operating base - **Singapore** — Asia operating presence - **Turkey** — Regional operating presence - **United States** — North American market presence - **China** — Asian market presence - Denmark is the headquarters and core R&D base - Singapore supports Asian commercial and operational reach - Turkey expands access to regional water-treatment markets - The United States is a key market for industrial and specialty use - China provides access to a large but competitive water-technology market ## Strategy Aquaporin's strategy centers on commercializing its Aquaporin Inside® technology across industrial, consumer, and specialized water-treatment uses. The company appears focused on scaling through partnerships and global market access while protecting its intellectual property and technical differentiation. Its long-term position depends on converting scientific capability into repeatable commercial deployments and broader adoption across water-intensive industries. - **Broaden commercialization of core membrane technology** (medium-term) — The company depends on turning its scientific platform into recurring commercial demand. - **Deepen partner-led market access** (short-term) — Partnerships can accelerate adoption and reduce the need for direct market build-out. - **Expand internationally** (medium-term) — Global water challenges create larger end markets than any single country can provide. - Commercialize Aquaporin Inside® across multiple water applications - Scale through partnerships and third-party manufacturing relationships - Grow industrial and reuse applications where water stress is acute - Expand international reach across Asia, Europe, and North America - Protect intellectual property as a core source of differentiation ## Risks Aquaporin faces execution risk because its products rely on commercialization of advanced technology, partner adoption, and successful scaling beyond early deployments. The company also faces supply-chain, manufacturing, and intellectual-property risks that are common in technology-driven industrial businesses. Geography adds regulatory and operational complexity, while end-market demand may be uneven across consumer, industrial, and partner channels. - **Limited commercialization experience** [high] — The report explicitly notes limited experience in commercializing the company's products. - **Dependence on third parties for manufacturing and inputs** [high] — Key product components and raw materials are sourced externally, creating supply and quality risk. - **Manufacturing disruptions** [medium] — Operational interruptions could delay shipments and affect customer confidence. - **Intellectual property protection** [high] — The business depends on proprietary biotechnology and nature-inspired membranes. - **Geographic execution risk in China** [medium] — Operating in China can involve competitive, regulatory, and partnership complexity. - Commercialization risk if products do not scale beyond early adoption - Reliance on third parties for components and raw materials - Manufacturing disruptions can affect delivery and consistency - IP protection is critical to preserve technology differentiation - International operations add regulatory and execution complexity ## Accounting As a technology company with evolving commercialization, Aquaporin likely depends on judgment around revenue timing, partner arrangements, and capitalization versus expensing of development activity. Investors should also watch estimates tied to inventory, recoverability of assets, and impairment testing if sales scale more slowly than expected. Because the business operates across multiple currencies and jurisdictions, translation effects and foreign exchange can also affect reported results. - **Revenue recognition** — Could shift revenue between periods depending on delivery or acceptance terms - **Development costs and intangible assets** — Affects reported operating result and asset base - **Impairment testing** — Could lead to non-cash write-downs - **Foreign currency translation** — Can cause volatility in reported equity and earnings - Revenue recognition may depend on product delivery and contract terms - Partner and license arrangements can affect timing of revenue - Development spend and intangible asset treatment may require judgment - Inventory and asset impairment risk if commercialization slows - Foreign currency translation matters across Denmark, Asia, and the US --- *Last updated: 2026-10-24T15:00:35.093493+00:00*